Ausdal Financial Partners, Inc. Becton Dickinson & CO Transaction History

Ausdal Financial Partners, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$230.08 - $250.94 $1,150 - $1,254	-5 Reduced 0.57%	871 $219,000
Q3 2021 Nov 01, 2021	BUY	$232.72 - $256.47 $1,163 - $1,282	5 Added 0.57%	876 $215,000
Q2 2021 Jul 19, 2021	BUY	$232.65 - $254.58 $4,653 - $5,091	20 Added 2.35%	871 $212,000
Q1 2021 May 05, 2021	BUY	$232.09 - $256.88 $197,508 - $218,604	851 New	851 $207,000
Q1 2020 May 04, 2020	SELL	$195.69 - $279.01 $152,246 - $217,069	-778 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$236.45 - $266.82 $183,958 - $207,585	778 New	778 $220,000
Q2 2019 Aug 05, 2019	SELL	$217.4 - $246.08 $175,441 - $198,586	-807 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$206.05 - $248.17 $166,282 - $200,273	807 New	807 $202,000
Q4 2018 Feb 11, 2019	SELL	$204.73 - $257.93 $237,896 - $299,714	-1,162 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$208.1 - $233.85 $241,812 - $271,733	1,162 New	1,162 $278,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Ausdal Financial Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ausdal Financial Partners, Inc. with notifications on news.